1,3,2-Diazaphospholidin-4-ones and 2-Sulfides 499
2
1H NMR and 31P NMR and MS data for compounds 2a–g and 3a–g
TABLE
31P NMR
(CDCl3)
P
Entry
1H NMR
(CDCl3)
EI-MS m/z (%)
H
2a
0.75–0.87 (t, 6H, 2 CH3), 2.87–3.12 (m,
107.18
327 (M+, 44.69), 255 (84.27), 122(100),
105 (20.37), 77 (54.19), 72 (9.36)
4H, 2 CH2, 3 JPH = 9.4 Hz), 4.21–4.41 (m,
2H, CH2 in the ring), 6.87–7.52 (m, 10H, Ar-H).
0.78–0.85 (t, 6H, 2 CH3), 2.29 (s, 3H,
2b
107.10
375 (M+, 62.02), 303 (100), 156 (96.50),
91 (52.23), 119 (39.30), 72 (13.12)
Me), 2.91–3.09 (m, 4H, 2 CH2,3 JPH
9.5 Hz), 4.17–4.38 (m, 2H, CH2 in
the ring), 6.8–7.5 (m, 8H, Ar-H).
=
2c
2d
0.75–0.82 (t, 6H, 2 CH3), 2.86–3.10 (m,
361 (M+, 13.51), 289 (20.77), 122 (100),
139 (10.96), 77 (64.32), 72 (12.56)
4H, 2 CH2, 3 JPH = 9.4 Hz), 4.08–4.36 (m,
2H, CH2 in the ring), 6.85–7.47 (m, 9H, Ar-H).
0.77–0.88 (t, 6H, 2 CH3), 2.96–3.11 (m,
107.25
375 (M+, 21.00), 303 (27.65), 136 (74.96),
91 (100), 72 (30.67)
4H, 2 CH2,3 JPH = 9.1Hz), 4.16–4.33 (m,
2H, CH2), 7.02–7.34 (m, 8H, Ar-H), 1.29
(s, 3H, Me).
2e
0.77–0.84 (t, 6H, 2 CH3), 2.93–.08
395 (M+, 47.90), 322 ( 82.65), 324 (54.82),
156 (100), 139 (43.75), 111 (40.07)
(m, 4H, 2 CH2, 3 JPH = 9.0 Hz),
4.14–4.35 (m, 2H, CH2), 6.84–7.38
(m, 8H, Ar-H).
2f
0.71–0.82 (t, 6H, 2 CH3), 2.86–3.10 (m,
106.38
105.97
405 (M+, 42.29), 333 (79.71), 335 (80.63),
122 (100), 185 (23.22), 77 (24.66)
4H, 2 CH2, 3 JPH = 9.6 Hz), 4.15–4.28 (m,
2H, CH2), 6.81–7.46 (m, 9H, Ar-H).
2g
0.77–0.84 (t, 6H, 2 CH3), 2.90–3.16 (m,
419 (M+, 49.95), 347 (95.73), 349 (95.67),
136 (100), 183 (28.41), 91 (39.53)
4H, 2 CH2, 3 JPH = 9.2 Hz), 4.12–4.25 (m,
2H, CH2), 6.78–7.40 (m, 8H, Ar-H), 2.34
(s, 3H, Me).
3a
3b
3c
3d
0.57–0.67 (t, 6H, 2 CH3), 2.98-3.20 (m,
4H, 2 CH2), 4.15–4.20 (m, 2H, CH2 in
the ring), 6.85–7.31 (m, 10H, Ar-H)
0.76–0.86 (t, 6H, 2 CH3), 2.98–3.32 (m,
4H, 2 CH2), 4.26–4.32 (m, 2H, CH2 in
the ring), 7.10–7.46 (m, 8H, Ar-H).
0.75–0.82 (t, 6H, 2 CH3), 3.01–3.48 (m,
4H, 2 CH2), 4.26–4.32 (m, 2H, CH2 in
the ring), 7.10–7.44 (m, 9H, Ar-H).
0.77–0.88 (t, 6H, 2 CH3), 2.38 (s, 3H,
CH3), 7.09–7.34 (m, 8H, Ar-H), 2.99–3.38
(m, 4H, 2 CH2), 4.26–4.31 (m, 2H, CH2
in the ring).
0.76–0.86 (t, 6H, 2 CH3), 2.98–3.32 (m,
4H, 2 CH2), 4.26–4.32 (m, 2H, CH2 in
the ring), 7.10–7.46 (m, 8H, Ar-H).
0.73–0.83 (t, 6H, 2 CH3), 3.13–3.48 (m,
4H, 2 CH2), 4.27–4.32 (m, 2H, CH2 in
the ring), 7.05–7.48 (m, 9H, Ar-H).
0.77–0.86 (t, 6H, 2 CH3), 2.99–3.41 (m,
4H, 2 CH2), 2.39 (s, 3H, CH3), 4.26–4.31
(m, 2H,CH2 in the ring), 7.06–7.48 (m, 8H,
Ar-H)
62.90
62.86
62.53
62.54
359 (M+, 23.92), 287 (4.87), 255 (86.4),
154 (20.57), 122 (85.64), 72 (100)
407 (M+, 38.64), 409 (M+ + 2,14.66),
335 (4.16), 303 (100), 156 (11.90),
72 (31.15)
393 (M+, 49.91), 395 (M+ + 2,20.61),
360 (6.65), 289 (100), 122 (30.84),
72 (27.47)
407 (M+, 44.20), 409 (M+ + 2,16.89),375
(4.67), 335 (6.50), 303 (100), 136 (23.78),
72 (24.01)
3e
3f
62.18
62.51
62.42
427 (M+, 34.72), 429 (M+ + 2,25.23), 355
(5.27), 357 (4.54), 323 (100), 156 (14.02),
72 (34.72)
437 (M+, 36.30), 366 (8.83), 335 (100),
122 (28.93), 72 (25.21).
3g
451 (M+, 42.86), 421 (5.14), 381 (9.42),
349 (100), 136 (22.67), 72 (22.97).
MHz spectrometer. Mass spectra were measured on
a HP 5988A spectrometer. Elemental analysis was
measured with a PE-2400 elementary analyzer. The
IR spectra were measured by using a Shimadzu-
408 instrument. Column chromatography was per-
formed on silica gel II (10-40, Hai Yang Chemical
Factory of Qingdao). All solvents and materials were
reagent grade and purified as required. 1,3-diaryl
glycinamides 1 were prepared according to the re-
ported procedure [7,10].